Anders Krarup‐Hansen

3.5k total citations · 1 hit paper
55 papers, 2.1k citations indexed

About

Anders Krarup‐Hansen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anders Krarup‐Hansen has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 11 papers in Surgery. Recurrent topics in Anders Krarup‐Hansen's work include Sarcoma Diagnosis and Treatment (22 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Vascular Tumors and Angiosarcomas (7 papers). Anders Krarup‐Hansen is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Vascular Tumors and Angiosarcomas (7 papers). Anders Krarup‐Hansen collaborates with scholars based in Denmark, United Kingdom and France. Anders Krarup‐Hansen's co-authors include Jean‐Yves Blay, Pancras C.W. Hogendoorn, Jaap Verweij, Patrick Schöffski, Peter Hohenberger, Sandrine Marréaud, Cyril Fisher, Ian Judson, Thierry Alcindor and C. Hermans and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Anders Krarup‐Hansen

54 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

2014 814 citations Patrick Schöffski, Jean‐Yves Blay et al. profile →

Peers

Countries citing papers authored by Anders Krarup‐Hansen

Since Specialization

Citations

This map shows the geographic impact of Anders Krarup‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Krarup‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Krarup‐Hansen more than expected).

Fields of papers citing papers by Anders Krarup‐Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Krarup‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Krarup‐Hansen. The network helps show where Anders Krarup‐Hansen may publish in the future.

Co-authorship network of co-authors of Anders Krarup‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Krarup‐Hansen. A scholar is included among the top collaborators of Anders Krarup‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Krarup‐Hansen. Anders Krarup‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Occlusive wound closure prevents prolonged wound discharge—A randomised controlled trial in patients undergoing tumour resection and endoprosthetic reconstruction of the proximal femur because of metastatic bone disease 2023 ·International Wound Journal ·Werner Hettwer, Chunsen Wu, P Horstmann, (unknown), Anders Krarup‐Hansen, Michael Mørk Petersen	3
2	Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study 2022 ·Anticancer Research ·(unknown), Ninna Aggerholm‐Pedersen, Tim Svenstrup Poulsen, (unknown), Pieter de Heer, Luit Penninga, Anders Krarup‐Hansen, Estrid Høgdall	1
3	Medical oncological treatment for patients with Gastrointestinal Stromal Tumor (GIST) – A systematic review 2022 ·Critical Reviews in Oncology/Hematology ·(unknown), Ninna Aggerholm‐Pedersen, Estrid Høgdall, Anders Krarup‐Hansen	9
4	The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients With Gastrointestinal Stromal Tumor 2022 ·Anticancer Research ·(unknown), Estrid Høgdall, Pieter de Heer, Luit Penninga, Rikke Bæk, Maléne Møller Jørgensen, Bodil Elisabeth Engelmann, Philip Rossen, (unknown), Anders Krarup‐Hansen, Ninna Aggerholm‐Pedersen	3
5	Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour 2021 ·Case Reports in Oncology ·(unknown), (unknown), Estrid Høgdall, Tim Svenstrup Poulsen, Anders Toxværd, (unknown), Magnus Bergenfeldt, Anders Krarup‐Hansen	5
6	Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST) 2021 ·ESMO Open ·Mikael Eriksson, Peter Reichardt, Heikki Joensuu, Anders Krarup‐Hansen, Oskar Hagberg, Peter Hohenberger, Hans Hagberg, L. Hansson, Theodoros Foukakis, Kalevi Pulkkanen, Sebastian Bauer, Dorota Goplen, (unknown), Kirsten Sundby Hall	8
7	Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study 2019 ·British Journal of Cancer ·Jean‐Yves Blay, Patrick Schöffski, Sebastian Bauer, Anders Krarup‐Hansen, Charlotte Benson, David R. D’Adamo, Yan Jia, Robert G. Maki	31
8	Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study. 2018 ·Journal of Clinical Oncology ·Martee L. Hensley, Danielle Enserro, Helen Hatcher, Petronella B. Ottevanger, Anders Krarup‐Hansen, Jean‐Yves Blay, Cyril Fisher, Katherine Moxley, Shashikant Lele, Jayanthi Lea, Krishnansu S. Tewari, Premal H. Thaker, Oliver Zivanovic, David M. O’Malley, Katina Robison, David S. Miller	6
9	Expansion of tumor specific tumor-infiltrating lymphocytes (TIL) from sarcoma and the potential benefit of anti-CD137 stimulation: A prerequisite for adoptive cell transfer (ACT) immunotherapy 2017 ·Annals of Oncology ·Morten Nielsen, Anders Krarup‐Hansen, (unknown), Michael Mørk Petersen, Anand C. Loya, Marie Christine Wulff Westergaard, Inge Marie Svane, Niels Junker	1
10	Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma 2016 ·Annals of Oncology ·Morten Nielsen, Anders Krarup‐Hansen, (unknown), Michael Mørk Petersen, Anand C. Loya, Niels Junker, Inge Marie Svane	1
11	Subgroup analysis of leiomyosarcoma (LMS) patients (pts) from a phase 3, open-label, randomized study of eribulin (ERI) versus dacarbazine (DTIC) in pts with advanced liposarcoma (LPS) and LMS 2016 ·Annals of Oncology ·Jean‐Yves Blay, Patrick Schöffski, Sebastian Bauer, Anders Krarup‐Hansen, Charlotte Benson, David R. D’Adamo, (unknown), Robert G. Maki	1
12	Left Ventricular Assist Device as Bridge to Recovery for Anthracycline‐Induced Terminal Heart Failure 2012 ·Congestive Heart Failure ·(unknown), Kåre Sander, Peter B. Hansen, Jacob Eifer Møller, Anders Krarup‐Hansen, Finn Gustafsson	12
13	Rising incidence of Merkel cell carcinoma 2011 ·Journal of Plastic Surgery and Hand Surgery ·(unknown), Jørgen Lock‐Andersen, Karin Dahlstrøm, Krzysztof T. Drzewiecki, Eva Balslev, Aida Muhic, Anders Krarup‐Hansen	36
14	Dosimetric and geometric evaluation of an open low-field magnetic resonance simulator for radiotherapy treatment planning of brain tumours 2008 ·Radiotherapy and Oncology ·Brian Kristensen, Finn Laursen, Vibeke Løgager, Poul Geertsen, Anders Krarup‐Hansen	41
15	Successful Resection of an Advanced Duodenal Gastrointestinal Stromal Tumor After Down-Staging with Imatinib: Report of a Case 2007 ·Surgery Today ·(unknown), Anders Toxværd, (unknown), Anders Krarup‐Hansen, Magnus Bergenfeldt	11
16	Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies 2006 ·Brain ·Anders Krarup‐Hansen, S. Helweg‐Larsen, H. Schmalbruch, Mikael Rørth, Christian Krarup	128
17	The determination of platinum in tissue of different human organs by means of neutron activation analysis 2002 ·Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) ·(unknown), (unknown), Anders Krarup‐Hansen	1
18	Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study 1992 ·Journal of Internal Medicine ·Bent Bruun Kristensen, Bent Ejlertsen, (unknown), Anders Krarup‐Hansen, Ib Transbøl, H.T. Mouridsen	14
19	Extra-visceral soft tissue sarcomas in adults: local treatment with special reference to irradiation 1989 ·Cancer Treatment Reviews ·Anders Krarup‐Hansen, Hans Skovgaard Poulsen	2
20	Pharmacokinetics of Doxorubicin in Man with Induced Acid or Alkaline Urine 1988 ·Acta Oncologica ·Anders Krarup‐Hansen, Karsten Wassermann, (unknown), M. Dalmark	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact